Opioid-Related Disorders
Conditions
Brief summary
The purpose of this study is to examine the interactions between buprenorphine and naltrexone, and to assess how they may directly impact the clinical issues involving: transferring patients from buprenorphine to naltrexone, developing a non-abusable form of buprenorphine, and enhancing patient acceptability of naltrexone.
Interventions
DRUGBuprenorphine/naloxone
Sponsors
University of Vermont
National Institute on Drug Abuse (NIDA)
Study design
Primary purpose
TREATMENT
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Please contact site for information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug use | — |
| Opioid agonist effects | — |
| Opiate withdrawal | — |
| Psychological changes in: pupil diameter, blood pressure, heart rate, respiration | — |
Countries
United States
Outcome results
None listed